Literature DB >> 15956830

Association between hematological parameters and high-density lipoprotein cholesterol.

Patrick M Moriarty1, Cheryl A Gibson.   

Abstract

PURPOSE OF REVIEW: The ability of high-density lipoprotein cholesterol to reverse atherosclerosis and reduce cardiovascular disease has been shown in several randomized controlled trials. One mechanism by which high-density lipoprotein cholesterol protects the vascular system includes hemorheology, the study of blood flow. RECENT
FINDINGS: Blood viscosity, or the resistance of flow, can be altered by red blood cell aggregation, red blood cell deformability, and plasma viscosity. Elevated high-density lipoprotein cholesterol levels may improve all of these rheological mediators. An infusion of recombinant high-density lipoprotein cholesterol can immediately release nitric oxide, a potent vasodilator and responder to changes in rheology, into the arteries by activation of endothelial nitric oxide synthase. The stimulation of nitric oxide release by high-density lipoprotein cholesterol may also alter blood rheology.
SUMMARY: In this article, we will review hemorheology, particularly blood viscosity along with other hemorheological factors, and examine their association with high-density lipoprotein cholesterol.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15956830     DOI: 10.1097/01.hco.0000167722.22453.47

Source DB:  PubMed          Journal:  Curr Opin Cardiol        ISSN: 0268-4705            Impact factor:   2.161


  6 in total

1.  Reduced high-density lipoprotein level is linked to worse ankle brachial index and peak oxygen uptake in postmenopausal women with peripheral arterial disease.

Authors:  Karin Mauer; J Emilio Exaire; Julie A Stoner; Leslie D Guthery; Polly S Montgomery; Andrew W Gardner
Journal:  Angiology       Date:  2010-06-07       Impact factor: 3.619

2.  Hemorheology and microvascular disorders.

Authors:  Young-Il Cho; Daniel J Cho
Journal:  Korean Circ J       Date:  2011-06-30       Impact factor: 3.243

3.  HELP apheresis in hypercholesterolemia and cardiovascular disease: efficacy and adverse events after 8,500 procedures.

Authors:  Frank van Buuren; Sven Kreickmann; Dieter Horstkotte; Tanja Kottmann; Klaus Peter Mellwig
Journal:  Clin Res Cardiol Suppl       Date:  2012-06

4.  Therapeutic apheresis in peripheral and retinal circulatory disorders.

Authors:  Alfonso Ramunni; Paola Brescia; Giuseppina De Fino; Giovanni Piscopo; Loreto Gesualdo
Journal:  Clin Res Cardiol Suppl       Date:  2012-06

5.  The Impact of Lipoprotein-Associated Oxidative Stress on Cell-Specific Microvesicle Release in Patients with Familial Hypercholesterolemia.

Authors:  M H Nielsen; H Irvine; S Vedel; B Raungaard; H Beck-Nielsen; A Handberg
Journal:  Oxid Med Cell Longev       Date:  2016-01-27       Impact factor: 6.543

6.  Supervised Cycling Training Improves Erythrocyte Rheology in Individuals With Peripheral Arterial Disease.

Authors:  Chih-Chin Hsu; Yu-Ting Lin; Tieh-Cheng Fu; Shu-Chun Huang; Cheng-Hsien Lin; Jong-Shyan Wang
Journal:  Front Physiol       Date:  2022-01-05       Impact factor: 4.566

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.